Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: J Heart Lung Transplant. 2023 Aug 5;42(12):1666–1677. doi: 10.1016/j.healun.2023.08.001

Table 2.

Medication tolerance

Time (Days after transplantation)

30 180 365 547 730 1095

Remaining in study
 NT 49 49 49 46 39 32
 ST 57 57 57 54 51 45
Maintenance Immunosuppression (# of medications)
 NT
2 0 4 (8%) 5 (10%) 6 (13%) 8 (21%) 10 (31%)
≥3 49 (100%) 45 (92%) 44 (90%) 40 (87%) 31 (79%) 22 (69%)
 ST
2 5 (9%) 7 (12%) 12 (21%) 12 (22%) 14 (27%) 14 (31%)
≥3 52 (91%) 50 (88%) 45 (79%) 42 (78%) 37 (73%) 31 (69%)
Cell cycle inhibitor (Yes)
 NT 49 (100%) 38 (78%) 37 (76%) 31 (67%) 27 (69%) 19 (59%)
 ST 48 (84%) 42 (74%) 30 (53%) 30 (56%) 24 (47%) 19 (42%)